Immunization with GP1 but not core-like particles displaying isolated receptor-binding epitopes elicits virus-neutralizing antibodies against junín virus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Vaccines ; 10 (2022), 2. - Art.-Nr. 173. - eISSN 2076-393X
- Schlagwort
-
Arenaviren
Immunreaktion
Glykoproteine
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2022
- Urheber
-
Roman-Sosa, Gleyder
Leske, Anne
Ficht, Xenia
Dau, Tung Huy
Holzerland, Julia
Hoenen, Thomas
Beer, Martin
Kammerer, Robert
Schirmbeck, Reinhold
Rey, Felix A.
Cordo, Sandra M.
Groseth, Allison
- DOI
-
10.18725/OPARU-50328
- URN
-
urn:nbn:de:bsz:289-oparu-50404-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Roman-Sosa, Gleyder
- Leske, Anne
- Ficht, Xenia
- Dau, Tung Huy
- Holzerland, Julia
- Hoenen, Thomas
- Beer, Martin
- Kammerer, Robert
- Schirmbeck, Reinhold
- Rey, Felix A.
- Cordo, Sandra M.
- Groseth, Allison
- Universität Ulm
Entstanden
- 2022
Ähnliche Objekte (12)
Human hepatitis D virus-specific T cell epitopes
Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Characterization of JC virus-specific CD4+ T cell epitopes in healthy individuals
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Identification of HIV-1 neutralizing antibodies and their epitopes from elite controllers by phage display
Retracted: Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Characterization of the Alfalfa Mosaic Virus as expression, presentation, delivery and screening system for potential epitopes derived from the Respiratory Syncytial Virus Fusion Protein
Human hepatitis D virus-specific T cell epitopes
Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Characterization of JC virus-specific CD4+ T cell epitopes in healthy individuals
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Identification of HIV-1 neutralizing antibodies and their epitopes from elite controllers by phage display
Retracted: Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Characterization of the Alfalfa Mosaic Virus as expression, presentation, delivery and screening system for potential epitopes derived from the Respiratory Syncytial Virus Fusion Protein
Human hepatitis D virus-specific T cell epitopes
Development of neutralizing and non-neutralizing antibodies targeting known and novel epitopes on Clostridioides difficile Toxin B
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Characterization of JC virus-specific CD4+ T cell epitopes in healthy individuals
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies
Identification of HIV-1 neutralizing antibodies and their epitopes from elite controllers by phage display
Retracted: Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies